Taylor Devices, Inc. — Form 10-Q Summary
Reporting period: The filing covers the fiscal quarter and nine months ended February 29, 2024, compared with February 28, 2023. Although the request labels the period “2023 Q3,” the filing identifies this as the quarter ended February 29, 2024. Taylor Devices designs and manufactures products including viscous damping devices used in structural and other applications.
Financial performance
| Metric | Three months ended Feb. 29, 2024 | Year-over-year change | Nine months ended Feb. 29, 2024 | Year-over-year change |
|---|---|---|---|---|
| Net sales | $12.25 million | +24% | $32.52 million | +10% |
| Gross profit | $5.75 million | +35% | $14.95 million | +23% |
| Gross margin | 47% | 43% prior year | 46% | 41% prior year |
| Operating income | $2.99 million | From $1.80 million | $6.97 million | +47% |
| Net income | $2.70 million | From $1.66 million | $6.53 million | +55% |
| Diluted EPS | $0.82 | From $0.47 | $1.91 | From $1.20 |
For the nine months, other income increased to $1.12 million from $0.43 million; the filing does not provide a detailed explanation for this increase. SG&A rose 18% to $7.66 million, primarily from employee compensation and incentive compensation. Research and development fell 64% to $0.32 million following completion of the Taylor Damped Moment Frame project.
Cash flow, balance sheet and liquidity
- Nine-month operating cash flow was $6.68 million, versus $1.34 million in the prior-year period. Investing activities provided $1.89 million, including proceeds from investment sales; financing activities used $9.08 million, including $9.53 million for treasury stock acquisition.
- At February 29, 2024, cash and cash equivalents were $3.06 million and short-term investments were $21.57 million, together $24.62 million, compared with $28.09 million at May 31, 2023. Current assets were $41.19 million and current liabilities $6.96 million.
- Total stockholders’ equity was $47.84 million, down from $50.09 million at May 31, 2023, reflecting the substantial share repurchase. The balance sheet reports no debt.
- Capital expenditures were $0.76 million for the nine months; the company also spent $0.30 million to acquire Pumpkin Mounts intellectual property. Capital expenditure commitments totaled $0.34 million for the next 12 months.
- Management believes operating cash flows are sufficient to fund operations and capital improvements for the next 12 months. The filing gives no formal earnings or revenue guidance.
Material changes and management commentary
- Year-to-date U.S. sales increased 21%, while sales to Asia declined 53%. Aerospace/defense sales rose 88%; sales to structural customers fell 35%, and industrial sales fell 18%. Aerospace/defense represented 61% of nine-month sales, versus 36% a year earlier.
- Management attributed margin improvement to pricing that recovered more material and labor cost increases, supplier visibility, continuous-improvement initiatives, and higher volume.
- Backlog was $30.2 million across 131 open sales orders at February 29, 2024, versus $27.8 million across 125 orders a year earlier. The company expects to recognize most of the current backlog in fiscal 2024 and 2025. Backlog was down from $32.5 million at May 31, 2023.
- The company repurchased 459,015 shares, approximately 13% of issued and outstanding shares, under a January 2024 redemption agreement for $19.92 per share, totaling approximately $9.14 million. The filing states this price was 87.6% of the average trading price on the January 8 closing date.
- Inventory increased 16% from May 31, 2023 to $8.04 million, including maintenance and other inventory. Management recorded $0.37 million of obsolescence provision in the nine-month period, versus $0.07 million a year earlier. Annualized inventory turnover declined to 3.1 from 3.5.
- Receivable days sales outstanding improved to 36 days from 47 at fiscal year-end. Costs and estimated earnings in excess of billings were $4.53 million; management expects to bill the balance within 12 months.
Risks, contingencies and other items
- The company is a third-party defendant in litigation relating to construction and alleged defects at 432 Park Avenue. The company disputes the allegations and says its damping devices were tested to the applicable specification. The plaintiff’s $125 million demand is against the building sponsor, not a stated quantified claim against Taylor Devices; the company says its potential damages cannot currently be estimated given limited discovery.
- Management identifies risks including customer capital-budget reductions, changing demand and industry capacity, competition and pricing pressure, technology changes, and natural disasters that may affect demand.
- The filing notes that results are not necessarily indicative of full-year results. Revenue on fixed-price contracts recognized over time depends on cost-to-complete estimates; losses on contracts are recognized when identified.
- The independent accountant’s interim review reported no material modifications needed for GAAP conformity; it was a review, not an audit. Management reported disclosure controls were effective and no material changes to internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether backlog converts to revenue as expected, and whether the customer, geographic, and project mix supports margins.
- Whether improved gross margins and operating cash flow persist alongside rising SG&A, inventory, and contract work-in-process.
- The cash and investment position after the large share repurchase, and the company’s plans for capacity expansion and capital spending.
- Developments in the 432 Park Avenue litigation, including any quantified claims or changes in management’s assessment of exposure.
- The drivers and sustainability of higher other income and the company’s ability to maintain liquidity without reported debt.